Previous close | 34.75 |
Open | 34.75 |
Bid | 33.50 |
Ask | 34.10 |
Strike | 300.00 |
Expiry date | 2024-09-20 |
Day's range | 34.75 - 34.75 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.